BioMed Research International / 2013 / Article / Tab 4

Clinical Study

Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool

Table 4

Treatment characteristics and results.

Patient numberTNM stage Tumor maximal diameter (mm)WB dose  (Gy)CCT/number of cycles Early toxicity grade (CTCAE v.4) Surgical specimen Pathological response
SkinDigestiveOther size (cm)Nodal status

1T4bN2aM010541.8Yes/4200507+/11PR
2T4cN2aM016050No110640/13PR
3T3N0M07550Yes/4201220/15PR
4T4bN2aM08546Yes/43104.52+/8PR
5 T3N2bM08846Yes/230317.61+/9PR

AJCC cancer staging manual, seventh edition (2010), WB: whole breast, CCT: concomitant chemotherapy, CTCAE: Common Toxicity Criteria for Adverse Events v.4, baseline evaluation before all treatments, delivered radiation dose, cardiovascular and/or pulmonary and/or hematological toxicity, *residual invasive malignant epithelial cells, interpretation at the Institut Curie of the concept proposed by Sataloff and colleagues (details in article), PR: partial response.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.